Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Dummer, Reinhard  [Clear All Filters]
Journal Article
Mehra T, Ikenberg K, Moos RMaria, Benz R, Nair G, Schanz U, Haralambieva E, Hoetzenecker W, Dummer R, French LEinar, et al. Brentuximab as a Treatment for CD30+ Mycosis Fungoides and Sézary Syndrome. JAMA Dermatol. 2014.
Brüggen M-C, Valencak J, Stranzenbach R, Li N, Stadler R, Jonak C, Bauer W, Porkert S, Blaschke A, Meiss F, et al. Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicentre study. J Eur Acad Dermatol Venereol. 2020.
He M, Soni B, Schwalie PC, Hüsser T, Waltzinger C, De Silva D, Prinz Y, Krümpelmann L, Calabro S, Matos I, et al. Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells. J Immunother Cancer. 2022;10(6).
Lehmann J, Caduff N, Krzywińska E, Stierli S, Salas-Bastos A, Loos B, Levesque MP, Dummer R, Stockmann C, Münz C, et al. Escape from NK cell tumor surveillance by NGFR-induced lipid remodeling in melanoma. Sci Adv. 2023;9(2):eadc8825.
Ramelyte E, Dummer R, Guenova E. Investigative drugs for the treatment of cutaneous T-cell lymphomas (CTCL): an update. Expert Opin Investig Drugs. 2019.
Schlenker R, Schwalie PC, Dettling S, Huesser T, Irmisch A, Mariani M, Gómez JMMartíne, Ribeiro A, Limani F, Herter S, et al. Myeloid-T cell interplay and cell state transitions associated with checkpoint inhibitor response in melanoma. Med. 2024.
DeSimone JA, Sodha P, Ignatova D, Dummer R, Cozzio A, Guenova E. Recent advances in primary cutaneous T-cell lymphoma. Curr Opin Oncol. 2015.
Morgenroth S, Roggo A, Pawlik L, Dummer R, Ramelyte E. What Is New in Cutaneous T Cell Lymphoma?. Curr Oncol Rep. 2023.
Varum S, Baggiolini A, Zurkirchen L, Atak ZKalender, Cantù C, Marzorati E, Bossart R, Wouters J, Häusel J, Tuncer E, et al. Yin Yang 1 Orchestrates a Metabolic Program Required for Both Neural Crest Development and Melanoma Formation. Cell Stem Cell. 2019;24(4):637-653.e9.